Cargando…
Mycophenolate for the Treatment of Primary Sjögren’s Syndrome
Primary Sjögren's syndrome (pSS) is a systemic autoimmune disease with exocrine gland dysfunction and multi-organ involvement. Currently, there is an increasing trend toward non-steroid therapy for the treatment of autoimmune diseases. Some biological agents or immunosuppressive drugs may be th...
Autores principales: | Chen, Weiqian, Lin, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534498/ https://www.ncbi.nlm.nih.gov/pubmed/33062590 http://dx.doi.org/10.2478/jtim-2020-0023 |
Ejemplares similares
-
Biomarkers for Primary Sjögren’s Syndrome
por: Chen, Weiqian, et al.
Publicado: (2015) -
Tph Cells Expanded in Primary Sjögren’s Syndrome
por: Chen, Weiqian, et al.
Publicado: (2022) -
Mycophenolate sodium treatment in patients with primary Sjögren syndrome: a pilot trial
por: Willeke, Peter, et al.
Publicado: (2007) -
Mesenchymal Stem Cells in Primary Sjögren's Syndrome: Prospective and Challenges
por: Chen, Weiqian, et al.
Publicado: (2018) -
Intravenous Immunoglobulin and Mycophenolate Mofetil for Long-Standing Sensory Neuronopathy in Sjögren's Syndrome
por: Danieli, Maria Giovanna, et al.
Publicado: (2012)